In the colon cancer cell lines HCT116 and SW480 treated with solanine, the expression of arachidonate 12-lipoxygenase B (ALOX12B) and arachidonate 5-lipoxygenase (ALOX5) was significantly upregulated in a dose-dependent manner. Here, ALOX5 is linked to malignant colon neoplasm.